CME Group (CME) Expected to Announce Quarterly Earnings on Wednesday

CME Group (NASDAQ:CME) is expected to be releasing its Q4 2025 results before the market opens on Wednesday, February 4th. Analysts expect the company to announce earnings of $2.69 per share and revenue of $1.6351 billion for the quarter. Investors may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Wednesday, February 4, 2026 at 8:30 AM ET.

CME Group Stock Up 0.2%

CME Group stock opened at $284.48 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group has a 1-year low of $232.32 and a 1-year high of $290.79. The firm’s fifty day simple moving average is $274.37 and its 200-day simple moving average is $272.05. The company has a market capitalization of $102.58 billion, a P/E ratio of 27.57, a P/E/G ratio of 3.20 and a beta of 0.27.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th were given a $1.25 dividend. The ex-dividend date of this dividend was Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s payout ratio is currently 48.45%.

Insider Transactions at CME Group

In related news, Director Harold Eugene Jr. Ford sold 1,000 shares of the business’s stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $263.53, for a total transaction of $263,530.00. Following the transaction, the director owned 1,091 shares of the company’s stock, valued at approximately $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction on Thursday, December 11th. The stock was sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the completion of the sale, the chief executive officer owned 65,804 shares in the company, valued at $17,737,468.20. This represents a 27.53% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by corporate insiders.

Institutional Trading of CME Group

A number of hedge funds have recently modified their holdings of the company. Strive Asset Management LLC bought a new stake in shares of CME Group during the third quarter valued at approximately $32,000. Osterweis Capital Management Inc. increased its holdings in CME Group by 7,580.0% in the 2nd quarter. Osterweis Capital Management Inc. now owns 384 shares of the financial services provider’s stock valued at $106,000 after buying an additional 379 shares during the period. Johnson Financial Group Inc. raised its stake in shares of CME Group by 15.9% in the 3rd quarter. Johnson Financial Group Inc. now owns 445 shares of the financial services provider’s stock valued at $120,000 after buying an additional 61 shares in the last quarter. Florida Financial Advisors LLC bought a new position in shares of CME Group during the 2nd quarter worth about $203,000. Finally, Clark Capital Management Group Inc. acquired a new stake in shares of CME Group during the 3rd quarter valued at about $242,000. Institutional investors own 87.75% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. Morgan Stanley decreased their price target on CME Group from $320.00 to $319.00 and set an “overweight” rating for the company in a research note on Thursday, January 15th. Raymond James Financial upped their target price on CME Group from $307.00 to $311.00 and gave the stock an “outperform” rating in a research report on Monday, January 5th. Keefe, Bruyette & Woods increased their price target on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CME Group from $310.00 to $318.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Finally, Jefferies Financial Group lowered their target price on shares of CME Group from $304.00 to $302.00 and set a “buy” rating on the stock in a research note on Monday, January 12th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $292.18.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.